Rimazolium

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H19N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 967Y95129A, chemically known as 3-(ethoxycarbonyl)-6,7,8,9-tetrahydro-1,6-dimethyl-4-oxo-4h-pyrido(1,2-a)pyrimidinium but generally known as rimazolium, which bears US NIH Compound Identifier 71940. European Medicines Agency schedules Rimazolium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15142MIG. World Health Organization schedules rimazolium in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, RIMAZOLIUM remains the US FDA Preferred Term for this commodity. Rimazolium bears US NLM identifiers UMLS ID C0072022 and NCI Concept Code C84138. SMILES: O=C1N2C(CCCC2[N](CC1C(=O)OCC)C)C.